These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13698454)

  • 1. Changes in glutamic acid-oxaloacetic acid-transaminase activity in the liver and kidneys on the effect of high doses of Pyramidon (aminopvrine).
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Can J Biochem Physiol; 1961 Jul; 39():1189-91. PubMed ID: 13698454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of large doses of pyramidon on glutamic-oxalic transaminase activity in the liver and kidneys].
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Kiserl Orvostud; 1961 Mar; 13():82-5. PubMed ID: 13698455
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental examination of the mechanism of pyramidon effect. 3. Effect of high pyramidon doses on the glutamic acid-oxaloacetic acid transaminase activity in serum.
    FAZEKAS AG; FAZEKAS IG; RENGEI B
    Can J Biochem Physiol; 1960 Aug; 38():899-901. PubMed ID: 13698448
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental examination of the mechanism of pyramidon effect. Effect of high pyramidon doses on renal function.
    FAZEKAS IG; FAZEKAS AG; BERTOK EF
    Arch Int Pharmacodyn Ther; 1960 Dec; 129():35-61. PubMed ID: 13698453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of glutamic-oxalic acid transaminase activity of the blood serum (SGOT) after massive doses of pyramidon].
    FAZEKAS A; FAZEKAS G; GYULA IG; RENGEI B
    Kiserl Orvostud; 1960 Oct; 12():490-3. PubMed ID: 13698446
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glutamic acid--pyruvic acid and glutamic acid-oxalacetic acid transaminase in maternal and embryonal organs, placenta, maternal serum and amniotic fluid of gravid rats in normal and pathological conditions].
    GOETZE T; GOETZE E
    Acta Biol Med Ger; 1961; 7():476-85. PubMed ID: 13899526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glutamic acid-oxalacetic acid transaminase determinations in human liver tissue].
    PIETSCHMANN H; WIEDERMANN G
    Wien Z Inn Med; 1959 Dec; 40():455-60. PubMed ID: 14432908
    [No Abstract]   [Full Text] [Related]  

  • 8. [The determination of alcohol dehydrogenase and glutamic acid oxalacetic acid transaminase activity in the human liver after death].
    KLEIN H; FAHRIG H; WOLF HP
    Dtsch Z Gesamte Gerichtl Med; 1962; 52():615-29. PubMed ID: 14456749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glutamic acid-oxalacetic acid transaminase in pathological changes of the horny layer of the epidermis].
    WEBER G
    Klin Wochenschr; 1959 Mar; 37(5):234-5. PubMed ID: 13642745
    [No Abstract]   [Full Text] [Related]  

  • 10. A kinetic and equilibrium analysis of the glutamic oxaloacetate transaminase mechanism.
    VELICK SF; VAVRA J
    J Biol Chem; 1962 Jul; 237():2109-22. PubMed ID: 13925259
    [No Abstract]   [Full Text] [Related]  

  • 11. [The behavior of serum glutamic acid-oxalacetic acid transaminase in myopathies and neurogenic muscle atrophies].
    KAESER HE
    Dtsch Z Nervenheilkd; 1959; 179():353-62. PubMed ID: 14408360
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glutamic-acid oxalacetic acid transaminase determinations in infancy and childhood. I. Studies in relation to hydrocephalus].
    SZABO L; SZABADOS T; ECK EH
    Acta Paediatr Acad Sci Hung; 1960; 1():199-209. PubMed ID: 13774428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glutamic acid-oxalacetic acid transaminase determinations in infancy and childhood II. Studies in connection with hydrocephalus].
    SZABO L; SZABADOS T; ECK EH
    Orv Hetil; 1960 Jan; 101():87-91. PubMed ID: 13836260
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutamic acid-oxalacetic acid transaminase in the spinal fluid in infectious diseases of the central nervous system.
    Krogsgaard AR; Quaade F
    Acta Neurol Scand; 1963; 39(2):154-60. PubMed ID: 14035914
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid-glutamic oxalacetic acid transaminase in patients receiving electroconvulsive therapy and in neurologic diseases.
    MANN SH; DEPASQUALE N; PATERSON R
    Neurology; 1960 Apr; 10():381-90. PubMed ID: 14420675
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the influence of roentgen total body irradiations on the activity of lactic acid dehydrogenase as well as glutamic acid-oxalacetic acid and glutamic acid-pyruvic acid transaminase in blood serum of rats].
    OSWALD H; GUENTHER PG; LORENZ W
    Strahlentherapie; 1959; 109():331-42. PubMed ID: 14429343
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the activity of basic phosphatases under the influence of massive doses of pyramidon].
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Kiserl Orvostud; 1961 Dec; 13():569-73. PubMed ID: 13891895
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in serum aldolase and alkaline phosphatase activity as effect of large doses of pyramidon (aminopyrine).
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Enzymologia; 1962 Jan; 24():7-13. PubMed ID: 13891894
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features.
    Czaja AJ; Wolf AM; Baggenstoss AH
    Gastroenterology; 1981 Apr; 80(4):687-92. PubMed ID: 6162704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.